PER 2025 International Symposium of Gastrointestinal Oncology (ISGIO)
Details
Physicians’ Education Resource®, LLC (PER®), is pleased to present the 2025 International Symposium of Gastrointestinal Oncology® (ISGIO), a 2-day, multidisciplinary educational conference dedicated to presenting and discussing the latest advances in the broad field of gastrointestinal (GI) cancer research, as well as critical issues relevant to the care of persons with GI cancer.
Management of GI malignancies has evolved across all disciplines, from screening to prognostication to treatment approaches of all modalities. However, many patients do not fall neatly into guideline-based treatment, and the volume of clinical trial data makes it difficult to parse findings that should inform treatment.
This highly engaging conference brings together world-renowned experts from different disciplines to educate clinicians using a combination of case-based learning, debates, and panel discussions. This dynamic, multi-format program is designed to be a comprehensive review of the emerging treatment landscape for GI cancers, with the goal of elucidating the complex array of recent studies that should inform clinician practice.
Learning Objectives
Upon completion of this activity, learners will be better able to:
- Incorporate biomarker testing results to individualize treatment selection for patients with GI cancers
- Evaluate the latest efficacy and safety data for newly approved agents, novel combinations, and novel agents to consider their potential impact on evolving treatment paradigms in GI cancers
- Develop personalized treatment plans for patients with GI cancers based on the latest evidence and practice guidelines
- Incorporate novel data to effectively sequence available therapies for optimal outcomes in patients with GI cancers
- Apply best practices and evidence-based proactive strategies to monitor and manage treatment-related adverse events in patients receiving novel therapies and combination regimens
Target Audience
This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in GI oncology. Other health care professionals interested in the treatment of these malignancies are also invited to participate.
Additional credit info
Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 11.25 Contact Hours.